NASDAQ: GRALV - GRAIL, LLC

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart GRAIL, LLC

Extended chart Simple chart
Financial Markets by TradingView

About GRAIL, LLC

GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California.

more details
GRAIL, LLC operates as a subsidiary of Illumina, Inc.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2024-06-12
Валюта usd
Валюта отчета usd
Сайт https://grail.com
Цена ао 14.96
Change price per day: 0% (14.96)
Change price per week: 0% (14.96)
Change price per month: 0% (14.96)
Change price per 3 month: 0% (14.96)
Change price per half year: 0% (14.96)
Change price per year to date: 0% (14.96)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % -32.8 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 67.61 8
Yield Ebitda, % 0 0
Yield EPS, % 424.46 10
Total: 7.6
More



Head Job title Payment Year of birth
Mr. Robert P. Ragusa Chief Executive Officer 1960 (65 years)
Dr. Joshua J. Ofman M.D., M.S.H.S President 1965 (60 years)
Mr. Aaron Freidin Chief Financial Officer
Mr. Paul Ciccolella Senior VP of Global Development & Operations
Ms. Amoolya Singh Ph.D. Senior VP of Research & Chief Scientific Officer
Mr. Abram Barth J.D., M.P.H. General Counsel
Ms. Julie Currie Chief People Officer
Mr. Rodger Currie VP and Head of Government Affairs & Alliance Development
Mr. Gautam K. Kollu Chief Commercial Officer 1974 (51 year)
Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng President Biopharma Business & Europe

Address: United States, Menlo Park, 1525 O’Brien Drive - open in Google maps, open in Yandex maps
Website: https://grail.com